Fewer than 1 in 100 patients with chronic hepatitis C get triple therapy

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:608 / 608
页数:1
相关论文
共 50 条
  • [1] ANEMIA IN A COHORT OF PATIENTS WITH CHRONIC HEPATITIS C ON TRIPLE THERAPY
    Llop, E.
    Cabezas, J.
    Selmo, J.
    de la Revilla, J.
    Martinez, J. L.
    Menendez, S.
    Pons, F.
    Torres, K.
    Trapero, M.
    Crespo, J.
    Calleja, J. L.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S349 - S350
  • [2] COST EFFECTIVENESS OF TRIPLE THERAPY FOR ADULTS PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C
    Araujo, R. L.
    Vianna, C. M.
    Mosegui, G. B.
    Rodrigues, M. P.
    Valle, P. M.
    Felicissimo, T.
    VALUE IN HEALTH, 2015, 18 (07) : A872 - A872
  • [3] Drug information and patients satisfaction in triple therapy for chronic hepatitis C
    Canamares-Orbis, I.
    Garcia-Munoz, C.
    Caro-Teller, J. M.
    Escribano-Valenciano, I.
    Gomez-Valbuena, I.
    Campo-Angora, M.
    Ferrari-Piquero, J. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1316 - 1316
  • [4] Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis?
    Ferenci, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (11-12) : 1407 - 1408
  • [5] Optimisation of triple therapy for patients with chronic hepatitis C: a systematic review
    Pecoraro, Valentina
    Cariani, Elisabetta
    Villa, Erica
    Trenti, Tommaso
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 (08) : 737 - 748
  • [6] Letter: telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis
    Wiegand, J.
    Maasoumy, B.
    Buggisch, P.
    Buslau, A.
    Schiefke, I.
    Berg, T.
    Wedemeyer, H.
    Sarrazin, C.
    Hinrichsen, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) : 1342 - 1344
  • [7] Telaprevir triple therapy in multimorbid chronic hepatitis C genotype 1 patients under hemodialysis
    Wiegand, Johannes
    Maasoumy, Benjamin
    Buggisch, Peter
    Buslau, Anna
    Schiefke, Ingolf
    Berg, Thomas
    Wedemeyer, Heiner
    Sarrazin, Christoph
    Hinrichsen, Holger
    HEPATOLOGY, 2013, 58 : 1112A - 1113A
  • [8] Real World Experience With Telaprevir-Based Triple Therapy for Genotype 1 Chronic Hepatitis C: More Than 100 Treated Patients in an Inner-City Hepatology Practice
    Arena, Rosemarie
    Ahmad, Danish
    Latimer, Dustin C.
    Golding, Linda
    Deuel, Jennifer L.
    Modi, Ronak
    Thapar, Manish
    Sass, David A.
    Rothstein, Kenneth
    GASTROENTEROLOGY, 2013, 144 (05) : S984 - S984
  • [9] Triple therapy for chronic hepatitis C: Practical Aspects
    Bakulin, I. G.
    Kiseleva, A. V.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (11) : 91 - 99
  • [10] Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis? Authors' reply
    Ogawa, E.
    Furusyo, N.
    Hayashi, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (11-12) : 1408 - 1408